private:tecrea
|
2540645
|
Jun 3rd, 2019 12:00AM
|
Tecrea Ltd
|
212
|
4.00
|
Open
|
Biotechnology
|
Jun 3rd, 2019 06:51PM
|
Jun 3rd, 2019 06:51PM
|
Tecrea Ltd is involved in basic research that results in transformative technologies for biomedicine. We focus on creative ways to use nanotechnology to improve cell delivery of reagents and drugs. We view cell delivery as a central problem in biological research and biomedicine, and improved delivery strategies can enable better application of many reagents and drugs. By improving delivery, Tecrea Ltd enables scientists to bring forward modern molecular medicines to the clinic.
Founded in 2012, as a spinout from the Royal Veterinary College, University of London, we have already developed a line of tools that improve scientific experiments through enhanced delivery of a range of molecules into cells. Our novel platform technology involves a safe to use polymer and nanotechnology. This may sound complicated, but our approach makes it easy. We believe that cell delivery technology should be effectively non-toxic to ensure experimental integrity and enable clinical progression. In line with this belief, our technology is uniquely non-toxic and effective. This combination of efficacy and safety enables us to provide value to customers and partners and we leading the field in this area of nanotechnology.
|
Open
|
Transfection, Small Molecule Drug Delivery, Plasmid Delivery, siRNA Delivery, Peptide Delivery, Protein Delivery, Drug Formulation, Antimicrobial Agents
|
Open
|
2 Royal College Street
|
London
|
|
GB
|
NW1 0NH
|
|
Tecrea
|
|
Health Care Equipment & Services
|
private:tecrea
|
2540645
|
Mar 9th, 2018 12:00AM
|
Tecrea Ltd
|
144
|
4.00
|
Open
|
Biotechnology
|
Mar 9th, 2018 08:27AM
|
Mar 9th, 2018 08:27AM
|
|
Open
|
|
|
|
|
|
|
|
|
Tecrea
|
|
Health Care Equipment & Services
|
private:tecrea
|
2540645
|
Feb 17th, 2018 12:00AM
|
Tecrea Ltd
|
136
|
4.00
|
Open
|
Biotechnology
|
Feb 17th, 2018 02:25PM
|
Feb 17th, 2018 02:25PM
|
Tecrea Ltd is involved in basic research that results in transformative technologies for biomedicine. We focus on creative ways to use nanotechnology to improve cell delivery of reagents and drugs. We view cell delivery as a central problem in biological research and biomedicine, and improved delivery strategies can enable better application of many reagents and drugs. By improving delivery, Tecrea Ltd enables scientists to bring forward modern molecular medicines to the clinic.
Founded in 2012, as a spinout from the Royal Veterinary College, University of London, we have already developed a line of tools that improve scientific experiments through enhanced delivery of a range of molecules into cells. Our novel platform technology involves a safe to use polymer and nanotechnology. This may sound complicated, but our approach makes it easy. We believe that cell delivery technology should be effectively non-toxic to ensure experimental integrity and enable clinical progression. In line with this belief, our technology is uniquely non-toxic and effective. This combination of efficacy and safety enables us to provide value to customers and partners and we leading the field in this area of nanotechnology.
|
|
|
|
|
|
|
|
|
|
Tecrea
|
|
Health Care Equipment & Services
|
private:tecrea
|
2540645
|
Feb 16th, 2018 12:00AM
|
Tecrea Ltd
|
136
|
4.00
|
Open
|
Biotechnology
|
Feb 16th, 2017 08:15AM
|
Feb 16th, 2017 08:15AM
|
Tecrea Ltd is involved in basic research that results in transformative technologies for biomedicine. We focus on creative ways to use nanotechnology to improve cell delivery of reagents and drugs. We view cell delivery as a central problem in biological research and biomedicine, and improved delivery strategies can enable better application of many reagents and drugs. By improving delivery, Tecrea Ltd enables scientists to bring forward modern molecular medicines to the clinic.
Founded in 2012, as a spinout from the Royal Veterinary College, University of London, we have already developed a line of tools that improve scientific experiments through enhanced delivery of a range of molecules into cells. Our novel platform technology involves a safe to use polymer and nanotechnology. This may sound complicated, but our approach makes it easy. We believe that cell delivery technology should be effectively non-toxic to ensure experimental integrity and enable clinical progression. In line with this belief, our technology is uniquely non-toxic and effective. This combination of efficacy and safety enables us to provide value to customers and partners and we leading the field in this area of nanotechnology.
|
|
|
|
|
|
|
|
|
|
Tecrea
|
|
Health Care Equipment & Services
|
private:tecrea
|
2540645
|
Feb 15th, 2018 12:00AM
|
Tecrea Ltd
|
136
|
4.00
|
Open
|
Biotechnology
|
Feb 15th, 2017 10:07AM
|
Feb 15th, 2017 10:07AM
|
Tecrea Ltd is involved in basic research that results in transformative technologies for biomedicine. We focus on creative ways to use nanotechnology to improve cell delivery of reagents and drugs. We view cell delivery as a central problem in biological research and biomedicine, and improved delivery strategies can enable better application of many reagents and drugs. By improving delivery, Tecrea Ltd enables scientists to bring forward modern molecular medicines to the clinic.
Founded in 2012, as a spinout from the Royal Veterinary College, University of London, we have already developed a line of tools that improve scientific experiments through enhanced delivery of a range of molecules into cells. Our novel platform technology involves a safe to use polymer and nanotechnology. This may sound complicated, but our approach makes it easy. We believe that cell delivery technology should be effectively non-toxic to ensure experimental integrity and enable clinical progression. In line with this belief, our technology is uniquely non-toxic and effective. This combination of efficacy and safety enables us to provide value to customers and partners and we leading the field in this area of nanotechnology.
|
|
|
|
|
|
|
|
|
|
Tecrea
|
|
Health Care Equipment & Services
|
private:tecrea
|
2540645
|
Feb 14th, 2018 12:00AM
|
Tecrea Ltd
|
136
|
4.00
|
Open
|
Biotechnology
|
Feb 14th, 2017 01:50PM
|
Feb 14th, 2017 01:50PM
|
Tecrea Ltd is involved in basic research that results in transformative technologies for biomedicine. We focus on creative ways to use nanotechnology to improve cell delivery of reagents and drugs. We view cell delivery as a central problem in biological research and biomedicine, and improved delivery strategies can enable better application of many reagents and drugs. By improving delivery, Tecrea Ltd enables scientists to bring forward modern molecular medicines to the clinic.
Founded in 2012, as a spinout from the Royal Veterinary College, University of London, we have already developed a line of tools that improve scientific experiments through enhanced delivery of a range of molecules into cells. Our novel platform technology involves a safe to use polymer and nanotechnology. This may sound complicated, but our approach makes it easy. We believe that cell delivery technology should be effectively non-toxic to ensure experimental integrity and enable clinical progression. In line with this belief, our technology is uniquely non-toxic and effective. This combination of efficacy and safety enables us to provide value to customers and partners and we leading the field in this area of nanotechnology.
|
|
|
|
|
|
|
|
|
|
Tecrea
|
|
Health Care Equipment & Services
|
private:tecrea
|
2540645
|
Feb 13th, 2018 12:00AM
|
Tecrea Ltd
|
136
|
4.00
|
Open
|
Biotechnology
|
Feb 13th, 2017 04:11PM
|
Feb 13th, 2017 04:11PM
|
Tecrea Ltd is involved in basic research that results in transformative technologies for biomedicine. We focus on creative ways to use nanotechnology to improve cell delivery of reagents and drugs. We view cell delivery as a central problem in biological research and biomedicine, and improved delivery strategies can enable better application of many reagents and drugs. By improving delivery, Tecrea Ltd enables scientists to bring forward modern molecular medicines to the clinic.
Founded in 2012, as a spinout from the Royal Veterinary College, University of London, we have already developed a line of tools that improve scientific experiments through enhanced delivery of a range of molecules into cells. Our novel platform technology involves a safe to use polymer and nanotechnology. This may sound complicated, but our approach makes it easy. We believe that cell delivery technology should be effectively non-toxic to ensure experimental integrity and enable clinical progression. In line with this belief, our technology is uniquely non-toxic and effective. This combination of efficacy and safety enables us to provide value to customers and partners and we leading the field in this area of nanotechnology.
|
|
|
|
|
|
|
|
|
|
Tecrea
|
|
Health Care Equipment & Services
|
private:tecrea
|
2540645
|
Feb 12th, 2018 12:00AM
|
Tecrea Ltd
|
136
|
4.00
|
Open
|
Biotechnology
|
Feb 12th, 2017 04:15AM
|
Feb 12th, 2017 04:15AM
|
Tecrea Ltd is involved in basic research that results in transformative technologies for biomedicine. We focus on creative ways to use nanotechnology to improve cell delivery of reagents and drugs. We view cell delivery as a central problem in biological research and biomedicine, and improved delivery strategies can enable better application of many reagents and drugs. By improving delivery, Tecrea Ltd enables scientists to bring forward modern molecular medicines to the clinic.
Founded in 2012, as a spinout from the Royal Veterinary College, University of London, we have already developed a line of tools that improve scientific experiments through enhanced delivery of a range of molecules into cells. Our novel platform technology involves a safe to use polymer and nanotechnology. This may sound complicated, but our approach makes it easy. We believe that cell delivery technology should be effectively non-toxic to ensure experimental integrity and enable clinical progression. In line with this belief, our technology is uniquely non-toxic and effective. This combination of efficacy and safety enables us to provide value to customers and partners and we leading the field in this area of nanotechnology.
|
|
|
|
|
|
|
|
|
|
Tecrea
|
|
Health Care Equipment & Services
|
private:tecrea
|
2540645
|
Feb 11th, 2018 12:00AM
|
Tecrea Ltd
|
136
|
4.00
|
Open
|
Biotechnology
|
Feb 11th, 2017 05:35AM
|
Feb 11th, 2017 05:35AM
|
Tecrea Ltd is involved in basic research that results in transformative technologies for biomedicine. We focus on creative ways to use nanotechnology to improve cell delivery of reagents and drugs. We view cell delivery as a central problem in biological research and biomedicine, and improved delivery strategies can enable better application of many reagents and drugs. By improving delivery, Tecrea Ltd enables scientists to bring forward modern molecular medicines to the clinic.
Founded in 2012, as a spinout from the Royal Veterinary College, University of London, we have already developed a line of tools that improve scientific experiments through enhanced delivery of a range of molecules into cells. Our novel platform technology involves a safe to use polymer and nanotechnology. This may sound complicated, but our approach makes it easy. We believe that cell delivery technology should be effectively non-toxic to ensure experimental integrity and enable clinical progression. In line with this belief, our technology is uniquely non-toxic and effective. This combination of efficacy and safety enables us to provide value to customers and partners and we leading the field in this area of nanotechnology.
|
|
|
|
|
|
|
|
|
|
Tecrea
|
|
Health Care Equipment & Services
|
private:tecrea
|
2540645
|
Feb 10th, 2018 12:00AM
|
Tecrea Ltd
|
136
|
4.00
|
Open
|
Biotechnology
|
Feb 10th, 2017 06:43AM
|
Feb 10th, 2017 06:43AM
|
Tecrea Ltd is involved in basic research that results in transformative technologies for biomedicine. We focus on creative ways to use nanotechnology to improve cell delivery of reagents and drugs. We view cell delivery as a central problem in biological research and biomedicine, and improved delivery strategies can enable better application of many reagents and drugs. By improving delivery, Tecrea Ltd enables scientists to bring forward modern molecular medicines to the clinic.
Founded in 2012, as a spinout from the Royal Veterinary College, University of London, we have already developed a line of tools that improve scientific experiments through enhanced delivery of a range of molecules into cells. Our novel platform technology involves a safe to use polymer and nanotechnology. This may sound complicated, but our approach makes it easy. We believe that cell delivery technology should be effectively non-toxic to ensure experimental integrity and enable clinical progression. In line with this belief, our technology is uniquely non-toxic and effective. This combination of efficacy and safety enables us to provide value to customers and partners and we leading the field in this area of nanotechnology.
|
|
|
|
|
|
|
|
|
|
Tecrea
|
|
Health Care Equipment & Services
|